ENDRA Life Sciences NDRA recently announced positive findings from a clinical study assessing the measurement consistency of its TAEUS Liver device. The evaluation demonstrated strong intra-operator ...
Hosted on MSN
Making sense of LI-RADS updates for liver care
LI-RADS is a standardized system for interpreting liver imaging, especially for patients at risk of hepatocellular carcinoma. The 2024 updates refine treatment response assessment, separating ...
Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring These thresholds ...
This prospective study included 135 patients (median age, 67 years; 66 women) who underwent MRI-guided SBRT for liver metastases across seven international centres between April 2019 and April 2023.
WASHINGTON & OXFORD, England--(BUSINESS WIRE)--Perspectum announced two research studies that were recently published, bringing hope to people with metabolic dysfunction-associated steatohepatitis ...
Scopics Announces New FDA Clearance for Hepatoscope® Expanding management of Liver disease complications. Company to exhibit at DDW 2026 Chicago.
Recent advances in CT, MRI, ultrasound, and AI are transforming liver disease diagnosis, enabling earlier, more accurate, and less invasive detection of conditions like fibrosis, steatosis, and ...
PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...
Non-alcoholic fatty liver disease (NAFLD) is increasing in prevalence worldwide. NAFLD is associated with excess risk of all-cause mortality, and its progression to non-alcoholic steatohepatitis (NASH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results